Preferred Label : Tyrosine Kinase Inhibitor IDRX-42;
NCIt definition : An orally bioavailable small molecule inhibitor of an as of yet undisclosed tyrosine
kinase, with potential antineoplastic activity. Upon oral administration, tyrosine
kinase inhibitor IDRX-42 inhibits the activity of an as of yet undisclosed tyrosine
kinase. This may result in antitumor activity in tumor cells in which the tyrosine
kinase is upregulated or dysregulated.;
Molecule name : IDRX 42; IDRX-42;
NCI Metathesaurus CUI : CL1798791;
Origin ID : C190128;
UMLS CUI : C5783514;
Semantic type(s)
- concept_is_in_subset
